Charles Theuer, President & CEO, Director at TRACON Pharmaceuticals, holds 406.42K shares in TRACON Pharmaceuticals (Ticker: TCON), holds 14.68K shares in Oncternal Therapeutics (Ticker: ONCT), holds ― shares in 4D Molecular Therapeutics (Ticker: FDMT).